These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 17915075)

  • 1. Targeted modulators of the endogenous cannabinoid system: future medications to treat addiction disorders and obesity.
    Janero DR; Makriyannis A
    Curr Psychiatry Rep; 2007 Oct; 9(5):365-73. PubMed ID: 17915075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacotherapeutic targeting of the endocannabinoid signaling system: drugs for obesity and the metabolic syndrome.
    Vemuri VK; Janero DR; Makriyannis A
    Physiol Behav; 2008 Mar; 93(4-5):671-86. PubMed ID: 18155257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endocannabinoid System: A Multi-Facet Therapeutic Target.
    Kaur R; Ambwani SR; Singh S
    Curr Clin Pharmacol; 2016; 11(2):110-7. PubMed ID: 27086601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endocannabinoid system involvement in brain reward processes related to drug abuse.
    Solinas M; Yasar S; Goldberg SR
    Pharmacol Res; 2007 Nov; 56(5):393-405. PubMed ID: 17936009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis.
    Cabranes A; Venderova K; de Lago E; Fezza F; Sánchez A; Mestre L; Valenti M; García-Merino A; Ramos JA; Di Marzo V; Fernández-Ruiz J
    Neurobiol Dis; 2005 Nov; 20(2):207-17. PubMed ID: 16242629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic potential of the endocannabinoid system in the brain.
    Ramos JA; González S; Sagredo O; Gómez-Ruiz M; Fernández-Ruiz J
    Mini Rev Med Chem; 2005 Jul; 5(7):609-17. PubMed ID: 16026307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoid receptor antagonists: pharmacological opportunities, clinical experience, and translational prognosis.
    Janero DR; Makriyannis A
    Expert Opin Emerg Drugs; 2009 Mar; 14(1):43-65. PubMed ID: 19249987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoid receptors as therapeutic targets.
    Mackie K
    Annu Rev Pharmacol Toxicol; 2006; 46():101-22. PubMed ID: 16402900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocannabinoids in appetite control and the treatment of obesity.
    Kirkham TC; Tucci SA
    CNS Neurol Disord Drug Targets; 2006 Jun; 5(3):272-92. PubMed ID: 16787229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The endocannabinoid system: physiology and pharmacology.
    Rodríguez de Fonseca F; Del Arco I; Bermudez-Silva FJ; Bilbao A; Cippitelli A; Navarro M
    Alcohol Alcohol; 2005; 40(1):2-14. PubMed ID: 15550444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The endocannabinoid system as a target for the treatment of cannabis dependence.
    Clapper JR; Mangieri RA; Piomelli D
    Neuropharmacology; 2009; 56 Suppl 1(Suppl 1):235-43. PubMed ID: 18691603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The endocannabinoid system and rimonabant: a new drug with a novel mechanism of action involving cannabinoid CB1 receptor antagonism--or inverse agonism--as potential obesity treatment and other therapeutic use.
    Xie S; Furjanic MA; Ferrara JJ; McAndrew NR; Ardino EL; Ngondara A; Bernstein Y; Thomas KJ; Kim E; Walker JM; Nagar S; Ward SJ; Raffa RB
    J Clin Pharm Ther; 2007 Jun; 32(3):209-31. PubMed ID: 17489873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The endocannabinoid system: a new molecular target for the treatment of tobacco addiction.
    Scherma M; Fadda P; Le Foll B; Forget B; Fratta W; Goldberg SR; Tanda G
    CNS Neurol Disord Drug Targets; 2008 Nov; 7(5):468-81. PubMed ID: 19128204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabinoids and the gut: new developments and emerging concepts.
    Izzo AA; Sharkey KA
    Pharmacol Ther; 2010 Apr; 126(1):21-38. PubMed ID: 20117132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the endocannabinoid system by organophosphorus nerve agents.
    Nomura DK; Blankman JL; Simon GM; Fujioka K; Issa RS; Ward AM; Cravatt BF; Casida JE
    Nat Chem Biol; 2008 Jun; 4(6):373-8. PubMed ID: 18438404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo pharmacology of endocannabinoids and their metabolic inhibitors: therapeutic implications in Parkinson's disease and abuse liability.
    Giuffrida A; McMahon LR
    Prostaglandins Other Lipid Mediat; 2010 Apr; 91(3-4):90-103. PubMed ID: 19523530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of the endocannabinoid system in drug addiction.
    Maldonado R; Valverde O; Berrendero F
    Trends Neurosci; 2006 Apr; 29(4):225-32. PubMed ID: 16483675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The emerging role of the endocannabinoid system in endocrine regulation and energy balance.
    Pagotto U; Marsicano G; Cota D; Lutz B; Pasquali R
    Endocr Rev; 2006 Feb; 27(1):73-100. PubMed ID: 16306385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Functional role of the endocannabinoid system in emotional homeostasis].
    Marco EM; Viveros MP
    Rev Neurol; 2009 Jan 1-15; 48(1):20-6. PubMed ID: 19145562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The endogenous cannabinoid system and its role in nociceptive behavior.
    Cravatt BF; Lichtman AH
    J Neurobiol; 2004 Oct; 61(1):149-60. PubMed ID: 15362158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.